284
It is perhaps the last chance to push the vaccination curve up a bit, which has been downhill for a long time. The first doses administered daily are very few, between 5 and 6 thousand, and so the Regions are hoping for Novavax. The “traditional” vaccine, which uses the same technology of drugs available for years against other diseases, could convince some No Vax, frightened by products based on messenger RNA, and raise the coverage a little more.